Expand DERM Menu
DERM MENU

DERM Stock Posts


DERM #JourneyMedical stock declines -17.9% in premarket,

Premarket Decliner

DERM Journey Medical8.54+0.67+8.5%

Premarket:7.01-1.53 (-17.9%)

Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Globe NewswireTue, 12-Aug 4:01 PM
DERM #JourneyMedical stock declines -16.9% in after hours trading. See the latest news.

After Hours Decliner

DERM Journey Medical8.54+0.67+8.5%

After Hours:7.10-1.44 (-16.9%)

Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Globe NewswireTue, 12-Aug 4:01 PM
DERM #JourneyMedical stock increases 5.6% after hours.

After Hours Gainer

DERM Journey Medical5.68+0.17+3.1%

After Hours:6.00+0.32 (+5.6%)

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

Globe NewswireThu, 11-Jul 4:05 PM
DERM #JourneyMedical stock increases 6.0% after hours.

After Hours Gainer

DERM Journey Medical5.68+0.17+3.1%

After Hours:6.02+0.34 (+6.0%)

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

Globe NewswireThu, 11-Jul 4:05 PM
DERM #JourneyMedical stock declines -7.1% in premarket,

Premarket Decliner

DERM Journey Medical5.39-0.11-2.0%

Premarket:5.01-0.38 (-7.1%)

Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products and Molecule Stabilizing Technology (MST) Franchise from VYNE Therapeutics, Inc.

Globe NewswireThu, 13-Jan 7:00 AM
Load Earlier Posts
Market Data Delayed 15 Minutes